Welcome to the all-new Vetlearn

  • Vetlearn is becoming part of NAVC VetFolio.
    Starting in January 2015, Compendium and
    Veterinary Technician articles will be available on
    NAVC VetFolio. VetFolio subscribers will have
    access to not only the journals, but also:
  • Over 500 hours of CE
  • Community forums to discuss tough cases
    and networking with your peers
  • Three years of select NAVC Conference
  • Free webinars for the entire healthcare team

To access Vetlearn, you must first sign in or register.


  Sign up now for:
Become a Member

Reference Desk February 2012

Novartis Resumes Distribution of Animal Health Brands in US and Canada

    GREENSBORO, North Carolina, February 2, 2012—Novartis Animal Health announced today that it is resuming the distribution and sale of already-manufactured supply of its leading pet health products from the Novartis plant in Lincoln, Neb. This action is being taken following consultation throughout January with the FDA.

    According to Rick Lloyd, General Manager of Novartis Animal Health in North America, the product stored in company warehouses at the time sales were stopped has resumed shipping to veterinarians in the US and Canada.

    “The well-being of pets is our top priority, so Novartis Animal Health took the time required in the past weeks to coordinate fully with the FDA and agree on the best course of action,” Lloyd said. “We thoroughly assessed all Animal Health products made at the plant. We are pleased to resume distribution of veterinary products that were ready for shipping at the time shipments were suspended.”

    The inventory now being released will be managed closely in order to assure the best availability to veterinarians and pet owners.

    “We understand first-hand the effort of getting pet owners to routinely comply with preventative medications,” said Elizabeth Bodner, DVM, Director of Technical Product Support US for Novartis Animal Health. “So we appreciate that this interruption in product availability is not without challenges to practices and pet owners.”

    In late December, Novartis temporarily stopped production and distribution of all products made at the Lincoln facility in order to focus on system and process upgrades at the site. These products included Novartis Animal Health US brands such as Interceptor® Flavor Tabs®, Sentinel® Flavor Tabs®, Clomicalm®, Program® Tablets and Suspension, and Milbemite®, as well as Interceptor, Sentinel, and Program Tablets sold in Canada. No veterinary products made at the Lincoln plant were recalled and all of the brands remain safe and effective when used according to the product label.

    “We would like to tell veterinarians and pet owners throughout the US and Canada just how much we regret the temporary supply disruption and the challenges it may have created,” Lloyd said. “Novartis Animal Health is committed to the highest standards of quality and care for pets. We want to ensure that we get back to normal production schedules as soon as possible.”

    About Novartis Animal Health US, Inc.

    Headquartered in Greensboro, NC, Novartis Animal Health US, Inc. researches, develops and commercializes leading animal treatments that meet the needs of pet owners, farmers and veterinarians. Part of the Basel, Switzerland-based Novartis Animal Health global organization, the US business is the largest of the 40 countries where Novartis Animal Health operates.  For more information about Novartis Animal Health US, Inc., please visit http://www.ah.novartis.us.

    Source: Novartis Animal Health


    Did you know... The science of neuroleadership focuses on the limbic system and the functions of various chemicals in the brain, such as dopamine and adrenaline, which affect behavior. Read More

    These Care Guides are written to help your clients understand common conditions. They are formatted to print and give to your clients for their information.

    Stay on top of all our latest content — sign up for the Vetlearn newsletters.
    • More